Buy or sell Deep Genomics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Deep Genomics Stock

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.

About Deep Genomics Stock

The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.

Funding History

November 2015$3.7M
September 2017$13.0M

Management

Co-Founder

Hannes Bretschneider

Research Scientist & Engineer

Alice Gao

Co-Founder

Hui Yuan Xiong

Co-Founder

Andrew Delong

Co-Founder and CEO

Brendan Frey

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Deep Genomics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 140K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo